OverviewChartTechnicalNewsTraderScreen

Prime Medicine Inc/  US74168J1016  /

NASDAQ
2024-04-25  5:41:22 PM Chg. -0.3100 Volume Bid5:43:44 PM Ask5:43:44 PM High Low
4.3900USD -6.60% 188,941
Turnover: 717,822.4377		 4.3900Bid Size: 1,400 4.4200Ask Size: 900 4.5983 4.3200
GlobeNewswire 04-23 Prime Medicine to Present Preclinical Data Demonstrating Broad Potential of Prime Editing Technology...
GlobeNewswire 03-01 Prime Medicine Reports Full Year 2023 Financial Results and Provides Business Updates
GlobeNewswire 02-28 Prime Medicine to Participate in Upcoming Investor Conferences
GlobeNewswire 02-20 Prime Medicine Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ O...
GlobeNewswire 02-15 Prime Medicine Announces Pricing of Upsized Public Offering
GlobeNewswire 02-14 Prime Medicine Announces Proposed Public Offering of Common Stock
GlobeNewswire 02-01 Prime Medicine to Present at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
GlobeNewswire 01-25 Prime Medicine Receives Up to $15 Million from Cystic Fibrosis Foundation to Advance Hotspot and PAS...
GlobeNewswire 01-05 Prime Medicine Appoints Allan Reine, M.D., as Chief Financial Officer
GlobeNewswire 01-02 Prime Medicine to Present at 42nd Annual J.P. Morgan Healthcare Conference
GlobeNewswire 2023-11-15 T-Therapeutics raises £48 million Series A for development of next generation TCR therapeutics to tr...
GlobeNewswire 2023-11-08 Prime Medicine to Present at Upcoming Investor Conferences
GlobeNewswire 2023-11-03 Prime Medicine Reports Third Quarter 2023 Financial Results and Provides Business Updates
GlobeNewswire 2023-10-27 Prime Medicine Presents First-ever Prime Editing Data in Non-human Primates Demonstrating Highly Eff...
GlobeNewswire 2023-10-24 Prime Medicine Presents First In Vivo Proof-of-Concept Prime Editing Data Demonstrating Ability of P...
GlobeNewswire 2023-10-17 Prime Medicine to Highlight Positive Preclinical Developments Across Prime Editing Pipeline and Plat...
GlobeNewswire 2023-09-19 Prime Medicine to Present at Upcoming Investor Conferences
GlobeNewswire 2023-09-08 Regeneron Announces Updates to Board of Directors
GlobeNewswire 2023-08-31 Prime Medicine to Present at Upcoming Investor Conferences
GlobeNewswire 2023-08-29 Better Life Partners Raises $26.5 Million in Series B Financing to Amplify and Scale its Hybrid Whol...